Business Meeting IG Infection & Allergy
Monday 18th June 2012
Agenda1. Lecture: "Clinical relevance of superantigens in allergic
disease. Task force conclusions".Professor Philippe Gevaert, Chair of the Task Force on Superantigens.
2. IG board and membership3. I&A sessions at EAACI 20124. I&A Allergy School Edinburgh5. Influenza vaccination in allergy – questionnaire6. Influenza summit Brussels7. New I&A task force – suggestions please
Board 2011-2013
Chairperson Jürgen SchwarzeUnited [email protected]
• Secretary Chrysanthi [email protected]
• Members Carsten [email protected] [email protected]
• JMA Affiliate Heidi [email protected]
• Webmaster Chrysanthi [email protected]
Membership (2010-2012)
I&A Sessions
at EAACI 2012
Oral abstract sessions
Sunday, 17 June 201210:30 - 12:00
"Role of infections in chronic inflammation"
Tuesday, 19 June 201215:30 - 17:00
"Interplay between infections and allergy"
• Saturday, 16 June 201214:00 - 15:30From Innate immunity to allergyIntestinal microbiota and allergic immune response, Charles Mackay, Australia
Sunday, 17 June 201213:30 - 15:00SymposiumNovel epidemiological insights on asthma and infectionRespiratory virus in the inception of childhood asthma, Robert Lemanske, United States
Role of rhinovirus C in childhood asthma, Peter Le Souef, Australia
Bacterial colonisation as a risk factor for initiation and expression, Hans Bisgaard, Denmark
15:30 - 17:00SymposiumHow can anti-infective drugs influence allergic disease?Antivirals, Peter Openshaw, United Kingdom
Antibiotics, Thibaut van Zele, Belgium
Antiparasitics, Maria Yazdanbakhsh, The Netherlands
15:30 - 17:00SymposiumMicrobiota, nutrition and allergic diseasesProbiotics and prebiotics for the prevention and treatment, Matthias Kopp, Germany
15:30 - 17:00JMA Scientific SymposiumBronchiolitis and the infant immune system, Maggina Paraskevi, Greece
• Monday, 18 June 201207:00 - 07:45Meet the ExpertsMeet the Expert 15 - Vaccinations in allergic children, Christoph Gruber, Germany
09:00 - 10:30Plenary Symposium 4Revisiting the origins of allergyHow does the microenvironment shape the allergic response?, Stephen Holgate, United Kingdom
10:45 - 12:15symposiumUnderstanding urticariaGerms and worms in urticaria, Peter Schmid-Grendelmeier, Switzerland
13:30 - 15:00Business Meeting Interest Group Infections & AllergyClinical relevance of superantigens in allergic disease. Task force conclusions, Philippe Gevaert, Belgium
15:30 - 17:00SymposiumViral mechanisms in airway inflammation Innate immune mechanisms in viral bronchiolitis - from mouse to infant, Riny Janssen, The Netherlands
Interferon response in virus-induced asthma, Sebastian Johnston, united Kingdom
Viral and bacterial interactions: their role in driving airway inflammation, Chrysanthi Skevaki, Greece
15:30 - 17:00SymposiumEAACI meets RussiaThe interaction of RSV and epithelial cells in the lung, Musa Khaitov, Russia
• Tuesday, 19 June 201208:30 - 10:00Meet the Expert 21Environmental pressure on epigenetic changes, William Cookson, United Kingdom
13:00 - 13:30Pro & Con 6Probiotics and prebiotics can reduces the incidence of infantile eczema, Pro: Philippe Eigenmann, SwitzerlandCon: Matthias Kopp, Germany
15:30 - 17:00Business MeetingAsthma SectionAsthma exacerbation, Sebastian Johnston
15:30 - 17:00Business MeetingPediatrics SectionPrebiotics and probiotics in allergy prevention and treatment: true or false?, Hania Szajewska, Poland
Wednesday, 20 June 201208:30 - 10:00Plenary Symposium 7Risk factors for allergyInfections at the inception of allergy, Nikos Papadopoulos, Greece
10:30 - 12:00SymposiumMolecular profiling of allergy and inflammationImmunoproteomics: inflammatory response to staphylococcal superantigens, Barbara Broker,
Clinical Impact and Mechanismsof Infections in Allergy
15 – 18 September 2011Edinburgh, UK
8
9
Clinical impact and mechanisms of infections in allergy
15 – 18 September 2011Edinburgh, UK
63 participants & 19 speakers
EAACI Members
13
EAACIJuniors
34
Non EAACI 14
63
28 Countries
UK 18
Russia 13
Germany 8
Greece 5
Austria, Belgium, Poland, The Netherlands
3
Switzerland, Thailand, Brazil, Republic of Korea, Slovenia, Romania
2
Ghana, Denmark, Kazakhstan, Canada, Portugal, USA, Uzbekistan, Sweden, Albania, India, Czech Republic, Bosnia, Japan, Turkey
1
ALLERGY SCHOOLS 2011
Local organizer: Jürgen Schwarze
13 CME credits
Influenza vaccination in allergyquestionnaire
• 241 respondents• 60% allergists, 30% paediatricians
• The majority of participants (82%) advocate their patients to become vaccinated
• Half of participants have been involved in influenza immunization programmes
• IFV immunization of asthmatic/allergic patients is largely performed by GPs and pediatricians
Does your department provide adequate staff and resources for influenza vaccination campaigns?
36.9
18.4 17.510.7 16.5
0
50
100
%
Resources for influenza vaccination campaignsare little or not adequate at all
Half of participants have been involved in influenza immunization programmes
EAACI I&A IG Survey 2012
Do you feel the level of influenza awareness among patients with asthma / respiratory allergy is satisfactory?
21.829.1 32.5
11.74.9
0
50
100
1-Not a
t all 2- 3- 4-
5-Completely
%
Half of physicians feel that the level of awareness among asthmatics
is little or not satisfactory at all
EAACI I&A IG Survey 2012
What is the vaccination rate of your asthmatic patients?
EAACI I&A IG Survey 2012
The majority estimates <40% vaccination coverage of their patients
Similarly, low estimates for asthma patients with egg allergy
I don't know/NA
28,4%
Other 71,6%
80-100%60-80%
40-60%
20-40%
1-20%
What are the reasons, beliefs, attitudes affecting declination rates among allergic individuals?
EAACI I&A IG Survey 2012
Declination of vaccination is strongly affected by a number of misconceptions
Education on vaccine
efficacy/safety should be one of
the priority public health
measures taken
Other 19,8%
Vaccination exacerbates
asthma 19,8%
Allergy to vaccine is common
20,3%
Vaccine is expensive 24%
Egg allergy precludes
vaccination 28,6%
Vaccination is responsible for flu symptoms
46,4%
Vaccination is painful 22,9%
What is the vaccination rate among physicians working in your Department?
16.5 19.1 15.4 14.9 13.8 20.2
0
50
100
1-20 %20-40 %
40-60 %60-80 %
80-100 %
I don't know/Does not apply
%
EAACI I&A IG Survey 2012
Half of respondents report vaccination rates <60% among physicians
• Additional resources are needed for vaccination campaigns.
• The level of influenza awareness among patients with asthma should be enhanced.
• Vaccination rate of asthmatic patients remains low despite recommendations by their physicians.
• Declination of vaccination among allergic individuals is affected by misconceptions, which may be cleared up with suitable education.
Conclusions
2nd ESWI Flu Summit
•Network of Partner Organizations: European Public Health Alliance, International Diabetes Federation-EU, WHO-EU, ESPID, EAP, EAACI, WONCA-EU, ELF, ERS, EMA, EUGMS, EUREGHA, National Influenza Vaccine Summit, PGEU
•Showcase successful projects that raised patients’ awareness
•~100 representatives of health care providers, senior citizens, at-risk patients and public health authorities: platform to expand efforts, exchange practices and initiate concrete actions, influenza challenges ahead
•WHO Europe (respir path progr), EC Directorate-General for Health and Consumers, ESWI Chair & Vice-Chair, EMA, American Medical Association, ESPID, Pharmacy Union, EUGMS, Turkish Ministry of Health
• Reported prevalence of influenza in AAE among children & adults
• Influenza attributable health care utilization
• Vaccine Effectiveness (CS intake)
• Vaccine Efficacy
• Vaccine Safety
• Selection of vaccine: TIV vs LAIV
• Compliance of asthmatics to current vaccine recommendations
Task Force: “Influenza in asthma”
18